Klclav Kid DT Tablet is a pediatric formulation combining Amoxycillin 200 mg and Clavulanic Acid 28.5 mg, designed to effectively treat bacterial infections in children. Amoxycillin, a broad-spectrum penicillin antibiotic, inhibits bacterial cell wall synthesis, leading to cell lysis and death. Clavulanic Acid acts as a beta-lactamase inhibitor, preventing enzymatic degradation of Amoxycillin by beta-lactamase-producing bacteria, thereby extending its antimicrobial spectrum. This combination is indicated for the treatment of various infections caused by susceptible organisms, including respiratory tract infections, otitis media, sinusitis, urinary tract infections, skin and soft tissue infections, and dental infections. Klclav Kid DT Tablet is formulated as a dispersible tablet, facilitating ease of administration and accurate dosing in pediatric patients who may have difficulty swallowing conventional tablets. The dosage regimen should be determined based on the severity of infection, patient age, and weight, adhering to established pediatric guidelines. Caution is advised in patients with a history of hypersensitivity to penicillins or beta-lactamase inhibitors. Common adverse effects may include gastrointestinal disturbances such as diarrhea, nausea, and vomiting. Use of Klclav Kid DT Tablet should be guided by susceptibility testing and clinical judgment to minimize resistance development.